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Abstract
Background: It is estimated that over 70% of patients with suspected malaria in sub-Saharan
Africa, diagnose and manage their illness at home without referral to a formal health clinic. Of those
patients who do attend a formal health clinic, malaria overdiagnosis rates are estimated to range
between 30–70%.
Methods: This paper details an observational cohort study documenting the number and cost of
repeat consultations as a result of malaria overdiagnosis at two health care providers in a rural
district of Mozambique. 535 adults and children with a clinical diagnosis of malaria were enrolled
and followed over a 21 day period to assess treatment regimen, symptoms, number and cost of
repeat visits to health providers in patients misdiagnosed with malaria compared to those with
confirmed malaria (determined by positive bloodfilm reading).
Results: Diagnosis based solely on clinical symptoms overdiagnosed 23% of children (<16y) and
31% of adults with malaria. Symptoms persisted (p = 0.023) and new ones developed (p < 0.001)
in more adults than children in the three weeks following initial presentation. Adults overdiagnosed
with malaria had more repeat visits (67% v 46%, p = 0.01–0.06) compared to those with true
malaria. There was no difference in costs between patients correctly or incorrectly diagnosed with
malaria. Median costs over three weeks were $0.28 for those who had one visit and $0.76 for ≥ 3
visits and were proportionally highest among the poorest (p < 0.001)
Conclusion:  Overdiagnosis of malaria results in a greater number of healthcare visits and
associated cost for adult patients. Additionally, it is clear that the poorest individuals pay
significantly more proportionally for their healthcare making it imperative that the treatment they
receive is correct in order to prevent wastage of limited economic resources. Thus, investment in
accurate malaria diagnosis and appropriate management at primary level is critical for improving
health outcomes and reducing poverty.
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Background
In sub-Saharan Africa over 70% of patients with suspected
malaria diagnose and manage their illness at home with
traditional remedies or drugs bought from local shops [1].
Attendance at a health clinic usually occurs only after
home treatment has failed. Primary level health facilities
lack tools for detection of malaria parasitaemia so a diag-
nosis of malaria is usually based on clinical symptoms
such as fever. Despite the development of algorithms to
improve the specificity of clinical malaria diagnosis, many
infectious diseases mimic malaria illness so this approach
leads to over diagnosis rates of 30–70% depending on
malaria transmission patterns [1,2]. Overdiagnosis of
malaria leads to unnecessary antimalarial drug use,
increased drug resistance, and delays in achieving the cor-
rect diagnosis: all of which prompt return visits to health
facilities.
Malaria misdiagnosis can either result in over estimating
or under estimating the burden of disease and in both
instances the burden of malaria misdiagnosis is likely to
fall most heavily on the poor and vulnerable because they
have less resilience to cope with the effects of prolonged
ill health [1]. There is almost no evidence available about
the economic impact of malaria misdiagnosis on house-
holds although there is information about the costs of
malaria episodes. Very low income households in Malawi
spent 32% of their annual household income on direct
and indirect costs for malaria illness compared to 4.2% in
more wealthy households [3]. In Sri Lanka, some families
spent more than 10% of their annual household income
per malaria episode [4] and children lost 10% of school
days [5]. Indirect costs, such as transport and days off
work for carers represented 79% of total costs of each
malaria episode in Ghana [6].
This study documented the number and cost of repeat
consultations with health providers in rural Mozambique
specifically as a result of malaria overdiagnosis. Such
information is important because many countries in sub-
Saharan Africa are introducing, or have recently intro-
duced, new malaria drug policies based on combination
therapies. These combinations are more expensive than
previous first-line drugs such as chloroquine and sul-
phadoxine-pyrimethamine (SP) and using them to treat
illnesses that are not truly malaria will be a significant
waste of resources as well as having a detrimental impact
on health outcomes and drug resistance. Recommended
malaria treatment in Mozambique at the time of this
study was amodiaquine and SP (AQ/SP).
High rates of overdiagnosis of malaria are well recognised
but have been tolerated because first-line antimalarial
drugs, such as chloroquine, were cheap. The introduction
of more expensive malaria treatments prompts the need
for better knowledge about the consequences of malaria
misdiagnosis to improve targeting of malaria drugs to
those who truly have malaria illness and to make sure that
the poorest benefit from these highly effective medicines
[7].
Methods
Study area
The study was conducted in Mocuba in central Mozam-
bique, a rural town 80 km from the Zambézia Provincial
capital of Quelimane with a population of 66,000.
Malaria is Mozambique's leading cause of morbidity and
mortality, with an estimated 44–67,000 deaths per
annum across all age groups [8]. The entire country is
endemic for malaria with perennial transmission in the
Zambézia Province peaking in January and April/May.
Over 90% of reported malaria cases are due to Plasmodium
falciparum. Mocuba town has a district hospital and two
health centres – one government-owned and one private
– which only deliver out-patient care. The study was con-
ducted at both health centres in order to maximise patient
enrolment.
Study design
This was an observational study to document the impact
on patients of malaria overdiagnosis that occurs during
routine malaria care. Patients who attended the clinics
were seen by a triage nurse and those with suspected
malaria were diagnosed clinically and treated according to
local protocols; all attempts were made not to interfere
with local practice, allowing clinic staff to diagnose and
treat patients as was customary. A full patient history and
temperature reading was taken from all patients. Only
first-line treatment with anti-malarial drugs is adminis-
tered at this level; severe cases are transferred to the district
hospital. Patients that had recently been diagnosed with
malaria and were returning to the clinic for follow-up tests
were excluded from the study. All patients who had a clin-
ical diagnosis of malaria, and who consented to take part
in the study, provided a finger prick blood sample for
malaria slides for microscopy. This was the only change
we made to the routine care of patients at the clinic and
was necessary to enable us to determine retrospectively
which patients truly had malaria; customarily, slides were
only taken in less than 10% of cases. Results from any
slides requested as part of routine clinical care were proc-
essed as normal and results given to triage nurse on the
same day. However the results of the blood slides did not
appear to alter the treatment regime as patients with neg-
ative results were still prescribed anti-malarials based on
the clinical diagnosis. The proportion of clinically diag-
nosed malaria patients who had malaria parasites was
determined by microscopy of Giemsa-stained thick blood
films by two independent researchers. Discrepant results
were resolved by an independent third microscopist.Malaria Journal 2008, 7:33 http://www.malariajournal.com/content/7/1/33
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Selection of study subjects
This study compared the household costs associated with
repeated health-related consultations between patients
correctly and incorrectly diagnosed with malaria in the
two health centres. Individuals attending either health
clinic in May-June 2004 with malaria clinically diagnosed
by the triage nurse, and resident within 10 km of the
health clinic (to facilitate patient follow up) were invited
to enrol in the study. Clinical diagnosis was based on the
presence of symptoms and fever at the time of enrolment,
according to the local protocol. Both adults and children
were enrolled, with children defined as those under 16
years of age and dependent on parental support.
Ethical approval
Permission for inclusion in the study was sought from all
adult participants, and from carers of child patients. The
Liverpool School of Tropical Medicine Research Ethics
Committee, the Director of Mozambique's National
Malaria Control Programme and the Zambézia Provincial
Medical Director granted ethical approval for the study.
Sample size calculation
After discussions with local health workers, a mean differ-
ence of 0.15 health consultations per patient per month
was considered to have important implications for local
public health. This figure was based on two malaria-
related health consultations per patient per annum. For
the study to have a 90% power (1-probability of a type II
error) to detect a difference of this size at a significant level
of 5% (probability of a type I error) the total number of
study patients required was 466.
Data collection and variables studied
Three questionnaires were used for data collection. The
first at day 0 when the patient first presented at the clinic
and then on days 7 and 21 when subjects were visited at
home. For children, questionnaires were completed by
the accompanying carer. Three weeks was chosen as the
period for follow up because this was sufficient time for
any self-limiting infection to have resolved and for any
underlying non-malarial cause of fever to have become
manifest and to have promoted repeat clinic visits. The
baseline questionnaire collected data on: age, sex, educa-
tion level (adults only), occupation (adults only), symp-
toms, transport and costs, missed wages (either to the
participant directly or to any family member accompany-
ing a sick individual), treatments and cost, and monthly
household outgoings. Monthly expenditure rather than
monthly income was collected as a pilot study indicated
that many individuals were unwilling to provide reliable
income data and that expenditure information would be
more accurate. Although chosen to be more accurate,
household expenditure remains a very difficult entity to
measure [9] and data was collected to provide an overview
rather than to conduct detailed analyses. The second and
third questionnaires collected additional data on: persist-
ence of initial symptoms, any additional symptoms and
number and cost of all health-related interactions (HIs)
either with the initial clinic or with other formal and
informal healthcare providers (e.g. dispensary, shop, tra-
ditional healer, hospital, other clinic, from relative).
Financial information was obtained in Mozambican Met-
icais (Mt) and converted to US Dollars (US$) using the
exchange rate at the time (23,000 Mt equivalent to
US$1.00).
Statistical analysis
The number of HIs by correctly and incorrectly diagnosed
individuals over the 21-day study period were compared
by fitting them to a Poisson model using the maximum
likelihood method and adjusting for overdispersion. P
values that were close to the significance threshold are
presented as a range with the lower value representing no
overdispersion and the higher value representing adjust-
ment for maximum overdispersion. Costs were compared
by Mann-Whitney Tests. Analyses were conducted in Sig-
maStat version 3.1 and STATA version 8.
Results
535 patients were enrolled in the study; 170 from the pri-
vate clinic and 365 from the government clinic. After the
21 day follow up and exclusion of those who did not meet
the inclusion criteria (specifically those individuals who
lived further than 10 km from the health centre than
reported) were correlated with the readable slide informa-
tion, data was available for 312 patients. Children consti-
tuted the majority of study participants (65%; 204/312)
with most individuals enrolled at the government clinic
(69%; 216/312) (Table 1). Because of referrals from ante-
natal clinics 71% of adults enrolled at the private clinic
and 66% at the government clinic were women. There was
no difference between the clinics in the age of adult par-
ticipants (p = 0.095, Mann-Whitney U test) but the aver-
age age of children was higher at the private clinic (p =
0.027, Mann-Whitney U test). 94% of adult participants
were subsistence farmers.
All 535 individuals enrolled in the study at day 0 had clin-
ically diagnosed malaria but only 396 (74%) had micro-
scopically confirmed parasitaemia. Clinical diagnosis of
malaria at both clinics was more reliable for children than
adults. 77% of malaria diagnoses in children and 69% in
adults were confirmed by microscopy (p = 0.093, χ2 test)
(Table 1). Although all enrolled patients were clinically
diagnosed with malaria, 41% of children (78/188) and
23% of adults (24/106) were not given prescriptions for
anti-malarial drugs at the initial visit (Table 2). Of the 192
patients who were given anti-malarials, 133 (69%)
received the nationally recommended AQ/SP combina-Malaria Journal 2008, 7:33 http://www.malariajournal.com/content/7/1/33
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tion, 37 (19%) received SP alone and the remainder
received monotherapy with chloroquine, quinine or amo-
diaquine. Retrospective analysis of antimalarial prescrip-
tions for adults with microscopically confirmed malaria,
revealed no difference in the anti-malarial drugs pre-
scribed for those with true malaria compared to those
with a false positive diagnosis (p = 0.933, χ2 test).
75 (37%) children and 43 (40%) adults still had their
original symptoms at day 7 but this had fallen to 33
Table 1: Characteristics of participants with clinically diagnosed malaria.
Description Private Government P value
Child Adult Child Adult
Sex Male (%) 25 (41) 10 (29) 69 (48 25 (34 P1 = 0.711
Female (%) 36 (59) 25 (71) 74 (52) 48 (66) P2 = 0.424
TOTAL 61 35 143 73
Age (years) Mean 3.03 33.57 2.6 30.15 P1 = 0.095
Range 0.5–13 18–60 0.2–14 16–61 P2 = 0.027
Occupation Unemployed (%) 3 (9)
Subsistence farmer (%) 11 (31) 4 (5)
Small trader (%) 4 (11) 21 (29)
State employee (%) 5 (14) 5 (7)
Professional (%) N/A 3 (9) N/A 10 (14)
Student (%) 4 (11) 2 (3)
Housewife (%) 4 (11) 10 (14)
Retired (%) 0 10 (14)
Other (%) 0 1 (1) 5(7)
Declined answer (%) 1 (3) 5(7)
Malaria 
microscopy
Positive (%) 83 (78) 43 (68) 197 (76) 74 (70) P1 = 0.968
Negative (5) 24 (22) 20 (32) 62 (24) 32 (30) P2 = 0.862
TOTAL 107 63 259 106
Median 
household 
monthly 
expenditure 
US$*
36.96 41.3 39.13 39.13 P1 = 0.738
P2 = 0.458
N/A = not applicable. *Sample size for mean monthly expenditure estimate: child private = 35, adult private = 21, child government = 87, adult 
government = 41. P values generated by chi-square or Mann-Whitney tests comparing adult1 and child2 participants respectively between clinics.
Table 2: Malaria treatment prescribed for patients with clinically diagnosed malaria at day 0 (n = 294; treatment regime not known for 
18 individuals). SP = sulfadoxine pyrimethamine.
Treatment Regime Total Adult Child
Microscopy 
positive
Microscopy 
negative
Microscopy 
positive
Microscopy 
negative
No antimalarial 112 17 (21.8%) 7 (25%) 43 (32.3%) 35 (63.6%)
Antimalarial  192 61 (78.2%) 21 (75%) 90 (67.7%) 20 (36.4%)
Amodiaquine/SP 133 44 20 57 12
Chloroquine 12 10 0 3 1
Q u i n i n e 11000
A m o d i a q u i n e  a l o n e 70061
S P  a l o n e3 76 12 46
Total 294 78 28 133 55Malaria Journal 2008, 7:33 http://www.malariajournal.com/content/7/1/33
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(16%) and 30 (28%) respectively by day 21. At day 21 but
not at day 7, prevalence of original symptoms was signif-
icantly higher in adults than in children (day 7 p = 0.933;
day 21 p = 0.023, χ2 test). 51 (25%) children and 41
(38%) adults had developed new symptoms such as anae-
mia, wheezing, cough, convulsions, diarrhoea, vomiting,
constipation and earache by day 7 and these persisted to
day 21 in 26 (24%) of adults and 15 (7%) of children. The
chance of new symptoms occurring was significantly
greater in adults compared to children at day 7 (p = 0.024,
χ2 test) and day 21 (p < 0.001, χ2 test). There was no sig-
nificant difference in persistence of original symptoms or
in recurrence of new symptoms between patients (either
adults or children) with a correct or incorrect diagnosis of
malaria at either 7 or 21 days.
The number of times individuals sought any HI during the
21 days after their initial visit varied from 0 (47%; 146/312
individuals) to nine (one individual). For the 53% of
patients who had more than one HI, the median number
of attendances was two (Table 3). 54% of children had one
or more HIs with no difference in frequency between those
with or without microscopy confirmed malaria (p = 0.879,
maximum likelihood estimation with adjustment for over-
dispersion). 46% of adults with microscopy confirmed
malaria had ≥ 1 HIs compared to 67% who were misdiag-
nosed with malaria (p = 0.01–0.06, maximum likelihood
estimation with adjustment for overdispersion). The
number of HIs by participants who had malaria confirmed
by microscopy were also analysed according to whether
they received anti-malarial treatment at day 0 or not. There
was no difference in HIs between the treated and untreated
group for children or adults. Although most repeat health
interactions occurred at the original health clinic (61% by
adults and 73% by children), 26% of interactions by adults
and 24% by children took place at local shops or tradi-
tional medicine providers (Figure 1).
Healthcare costs incurred by patients over the 21 days fol-
lowing their initial presentation were analysed by clinic
because of the different consultation fees charged by the
private and government clinics ($0.21 and $0.04 respec-
tively). The median and 25–75th percentile results are pre-
sented because the results were not normally distributed
(Table 4). Median costs were higher at the private clinic
($0.57, $0.43–0.87 for children and $0.74, 0.54–1.03 for
adults at the private clinic; $0.28, 0.15–0.52 and $0.48,
0.24–0.85 at the government clinic). The distribution of
expenditure between medications and consultations was
similar in adults and children with adults spending 77%
Providers of health care for A. children (N = 108) and B.  adults (N = 56) with clinical diagnosis of malaria who sought  additional health interactions over the 21-day study period Figure 1
Providers of health care for A. children (N = 108) and 
B. adults (N = 56) with clinical diagnosis of malaria 
who sought additional health interactions over the 
21-day study period.
Original clinic
Traditional medicine
Dispensary
Hospital
Other
Shop
Relative
A
B
Table 3: Number (%) of health interactions sought by adults and children over the 21-day study period.
Adult Child
Repeat Visit 
Number
Malaria microscopy 
negative
Malaria microscopy 
positive
Malaria microscopy 
negative
Malaria microscopy 
positive
0 10 (33) 42 (54) 29 (45) 65 (45)
1 8 (27) 12 (15) 13 (22) 27 (19)
2 4 (13) 13 (17) 4 (7) 30 (21)
3 5 (17) 4 (5) 6 (10) 10 (7)
4 1 (3) 6 (7) 4 (7) 9 (6)
5–9 2 (6) 1 (1) 3 (5) 4 (3)
T o t a l 3 07 85 9 1 4 5Malaria Journal 2008, 7:33 http://www.malariajournal.com/content/7/1/33
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on medications and 23% on consultations and children
spending 76% and 24%. There was no difference in costs
between patients correctly or incorrectly diagnosed with
malaria. The number of HIs correlated positively (r =
0.439, p < 0.0001) with the costs incurred over the 21 day
period with median costs of HIs by adults and children
ranging from $0.28 for the initial visit to $0.51 for 1 HIs,
$0.52 for 2 HIs, $0.76 for ≥ 3 HIs.
Monthly household expenditure varied widely from $9–
174 and did not differ significantly between those attend-
ing the private and government clinics (p = 0.826, Mann-
Whitney U test). Median monthly expenditure was lowest
in the households of children presenting to the private
clinic (US$36.96) and highest in the households of adults
presenting at the private clinics (US$41.3). Health costs
over the 21 day study period ranged from $0.1–19.3
(median 1.1) and were proportionally significantly higher
(p < 0.001, Mann-Whitney U test) in patients with a
household expenditure of ≤ $40/month (i.e. the lowest
quintile of household expenditure) compared to those
with household expenditure $40–200 (Figure 2). Match-
ing data about loss of earnings (i.e. indirect costs) and
monthly expenditure was available for 20 adults and 38
carers. The amount of earnings lost through ill health or
by having to take time off work to look after a sick family
member varied widely from <$0.01 – $21.7. The median
proportion of monthly expenditure that these lost earn-
ings represented was 2.1% for those with expenditures
<$40/month and 1.3% for those with expenditure >$40/
month (p = 0.229, Mann-Whitney U test).
Discussion
Findings
In this study, malaria overdiagnosis rates based on clinical
features alone were 23% in children and 31% in adults in
rural health clinics in malaria endemic Mozambique.
Despite all study patients having a clinical diagnosis of
malaria, only 59% of children and 77% of adults were
given prescriptions for anti-malarial drugs, and 31% of
these prescriptions were for drugs that were not first line
treatment in Mozambique's national malaria policy at
that time. There is no obvious rationalization for these
disparities in prescription rate and drug choice, but they
highlight a very worrying issue and it is important to
know whether the trend is unique to this setting or repre-
sentative of a wider scale problem.
A surprisingly high number of patients (53%) sought fur-
ther health advice after their initial consultation and 25%
of these interactions took place with traditional medicine
outlets or shops rather than the clinic they had originally
attended. Three weeks after the initial consultation, 28%
of adults still had their original symptoms and one week
after initial consultation 38% of adults had developed
new symptoms. These clinical outcomes were signifi-
cantly worse in adults than in children who overall had a
higher proportion of correct malaria diagnoses. Adults
who had been overdiagnosed with malaria had signifi-
cantly more health consultations during the following
three weeks than those who had been correctly diagnosed.
There was no difference in expenditure on health care dur-
Adult and child health costs as % of monthly expenditure (US  $) (filled circles = adult; unfilled circles = child) Figure 2
Adult and child health costs as % of monthly expendi-
ture (US $) (filled circles = adult; unfilled circles = 
child).
Monthly expenditure ($)
0 20 40 60 80 100 120 140 160 180 200
0
5
10
15
20
25
Table 4: Costs of HIs incurred by adults and children who were correctly and incorrectly diagnosed with malaria at the private and 
government clinics.
Cost US$ Private (US$) Government (US$)
Child Adult Child Adult
Malaria 
diagnosis 
correct
Malaria 
diagnosis 
incorrect
Malaria 
diagnosis 
correct
Malaria 
diagnosis 
incorrect
Malaria 
diagnosis 
correct
Malaria 
diagnosis 
incorrect
Malaria 
diagnosis 
correct
Malaria 
diagnosis 
incorrect
Median 0.62 0.52 0.74 0.73 0.39 0.29 0.45 0.48
25th-75th % 0.44–0.92 0.44–0.59 0.57–1.12 0.46–0.80 0.15–0.48 0.13–0.72 0.22–0.65 0.37–0.91
n 4 81 32 8 7 9 74 65 02 3Malaria Journal 2008, 7:33 http://www.malariajournal.com/content/7/1/33
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ing this period between patients correctly or incorrectly
diagnosed with malaria and this may have been related to
inconsistencies in antimalarial treatment for both groups
as well as wide variation in health expenditure between
individuals. Total health costs and lost earnings as a pro-
portion of monthly expenditure during the three weeks
were significantly higher in the poorest households.
Comparison with other studies
The rates of malaria overdiagnosis using clinical features
alone in this study and the inconsistencies in anti-malar-
ial treatment are very similar to findings from other stud-
ies [1,2,10]. This study exemplifies some of the challenges
that have been described in the literature in ensuring
implementation of new malaria treatment policies. These
challenges include encouraging appropriate health-seek-
ing behaviour for diagnosis for fever [11], ensuring drugs
reach the poorest households [7] and lack of management
capacity to ensure that drugs are only given to confirmed
malaria cases [12].
Published studies about the household costs of malaria
illness highlight the need to take account of both direct
and indirect costs and the disproportionately high eco-
nomic burden that malaria places on the poorest house-
holds [4]. Several studies in developing countries have
shown that indirect costs (time missed from work) are
around three times higher than direct costs (medications
and consultations) [13-15]. All these studies considered
the cost of individual episodes of malaria rather than the
economic impact on households of repeated health visits
due to misdiagnosis. A study of individual malaria epi-
sodes from Myanmar, showed that the duration of illness,
low income and days lost from work by accompanying
persons were associated with higher costs and the authors
suggested that the use of confirmatory diagnosis could
contribute to minimising the household burden of
malaria [14]. The prolonged ill health, and the high fre-
quency and cost of repeated health interactions following
clinical diagnosis of malaria found in this study support
this suggestion.
Limitations
Because this was an observational study and confirmation
of true malaria infections was done retrospectively, there
were no alterations in clinical practice at the health clinics.
The inconsistent prescribing of anti-malaria drugs for clin-
ically diagnosed malaria patients, and the occasional use
during follow up visits of malaria microscopy results of
unknown quality, meant that it was difficult to draw con-
clusions from data that compared outcomes and costs
between those with true and overdiagnosed malaria.
Although patients reporting to the formal health clinics in
Mocuba were accessed, during the study period, it is rec-
ognized that individuals who never access these formal
health services may have been excluded and that these
individuals are, potentially, most at risk from the conse-
quences of malaria infection.
Health-seeking behaviour was not specifically examined
in this study but could confound our results about fre-
quency and cost of health interactions as it is influenced
by many factors such as the patient or carers' (usually
women) ability to make decisions about types of health
care and to access money [16]. Ineffective malarial treat-
ment would have reduced the differential in health con-
sultation frequency between those correctly and
incorrectly diagnosed with malaria and despite this the
data indicated a strong trend towards increased health
consultations in adult patients who were overdiagnosed
with malaria.
The true costs of overdiagnosis for malaria negative
patients cannot be strictly inferred as there is no way of
knowing what would have happened to these individuals
if a confirmed negative diagnosis had been available. That
is to say, if a slide negative individual had been investi-
gated and treated for a non-malaria cause of their symp-
toms, what the costs of their diagnosis and subsequent
treatment would have been and whether their symptoms
would have resolved and how this would have affected
the number of repeat visits. It was not possible to answer
these questions in our study because it was an observa-
tional study so changes to regular practice were not feasi-
ble and the health facilities had very limited resources to
investigate non-malaria causes of symptoms.
The malaria overdiagnosis rates and costs presented in
this study may not be transferable to other contexts where
malaria transmission patterns, health-seeking behaviour
and health systems differ from those in rural Mozam-
bique. However, the consequences of failing to confirm
clinically diagnosed malaria infections, particularly on the
poorest households, will be common to many communi-
ties in sub-Saharan African countries.
Implications
Malaria overdiagnosis rates using clinical features alone
continue to be unacceptably high in all patients except
young children living in areas of intense transmission
[17]. Malaria microscopy, the gold standard for malaria
diagnosis, has accuracy in routine use of 70–75% and
costs less than $0.5 a test but is not usually provided at
primary level facilities because it requires trained and
supervised microscopists, well-maintained microscopes
and systems for checking quality [18]. A simpler diagnos-
tic test, the rapid malaria antigen detection dipstick [17] is
becoming affordable (<$1/test), is easy to use and is par-
ticularly useful for excluding malaria infection. Even
when diagnosis is used correctly, overdiagnosis is likely toPublish with BioMed Central    and   every 
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occur as it is widely recognised that febrile individuals in
endemic areas may have a detectable parasitaemia with-
out suffering from clinical malaria. This study emphasizes
that much more needs to be done to evaluate and deploy
methods for confirming malaria infection at community
level and in encouraging patients to seek accurate malaria
diagnosis [11]. Such tools are essential to enable drugs to
be targeted to those who truly have disease and their cost-
effectiveness increases as anti-malarial drugs become
more expensive. Combining accurate diagnosis with effi-
cient strategies to target at risk groups, e.g. intermittent
preventive treatment need to be complimented by proto-
cols for the management of malaria-negative fevers. The
current regime of over prescribing antimalarial drugs
leads to wasted resources, promotion of drug resistance,
prolonged ill health, reduced productivity and increased
costs for patients and the health service.
Conclusion
It has been postulated that possible consequences of
malaria misdiagnosis include prolonged ill health,
increased costs and loss of faith in formal health services
but there is very little evidence to support these sugges-
tions [16]. In this study, adults suffered higher rates of
malaria overdiagnosis than children and had more pro-
longed symptoms and a higher incidence of new prob-
lems. This suggests that, for many of these adults their
underlying condition had not been adequately managed
and was deteriorating. Adults with overdiagnosed malaria
had increased rates of repeat health interactions. Repeated
interactions incurred higher costs, which placed a dispro-
portionate economic burden on the poorest households
and many chose, or were forced, to seek help outside the
formal sector.
It is those who are unable to access sophisticated diagnos-
tic services for malaria who are hardest hit by the invisible
burden of malaria misdiagnosis. Much more needs to be
done to improve and promote access to accurate malaria
diagnosis for the poorest communities. For them, the con-
sequences of malaria misdiagnosis contribute to a vicious
cycle of increasing ill-health and deepening poverty.
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